Related references
Note: Only part of the references are listed.Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
You Li et al.
LANCET (2022)
Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy
Eric A. F. Simoes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
Laura L. Hammitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life
Andrea G. Buchwald et al.
CLINICAL INFECTIOUS DISEASES (2021)
Inferring high-resolution human mixing patterns for disease modeling
Dina Mistry et al.
NATURE COMMUNICATIONS (2021)
Epidemiology of respiratory syncytial virus in a community birth cohort of infants in the first 2 years of life
Mari D. Takashima et al.
EUROPEAN JOURNAL OF PEDIATRICS (2021)
Vaccination Coverage by Age 24 Months Among Children Born in 2017 and 2018 — National Immunization Survey-Child, United States, 2018–2020
Holly A. Hill et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study
You Li et al.
LANCET INFECTIOUS DISEASES (2021)
Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US
Zhe Zheng et al.
JAMA NETWORK OPEN (2021)
Preventing respiratory syncytial virus (RSV) disease in children After many decades, promising strategies for RSV immunization are on the horizon
Ruth A. Karron
SCIENCE (2021)
Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand
Namrata Prasad et al.
VACCINE (2021)
Community factors associated with local epidemic timing of respiratory syncytial virus: A spatiotemporal modeling study
Zhe Zheng et al.
SCIENCE ADVANCES (2021)
Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, Canada
Shokoofeh Nourbakhsh et al.
ECLINICALMEDICINE (2021)
Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study
Koos Korsten et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children
Ruth A. Karron et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children
Elizabeth J. McFarland et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naive infants
Sarah K. Browne et al.
VACCINE (2020)
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children
Elizabeth J. McFarland et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
S. A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
M. Pamela Griffin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination
Michiel van Boven et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Incidence of respiratory syncytial virus related health care utilization in the United States
Sabine Tong et al.
JOURNAL OF GLOBAL HEALTH (2020)
Influenza and Tdap Vaccination Coverage Among Pregnant Women - United States, April 2020
Hilda Razzaghi et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis
David Hodgson et al.
BMC MEDICINE (2020)
Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
Patricia T. Campbell et al.
BMC MEDICINE (2020)
Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016
Birgitte K. Giersing et al.
VACCINE (2019)
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children
Ursula J. Buchholz et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children
Elizabeth J. McFarland et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants
Joseph B. Domachowske et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2018)
Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children
Eric A. F. Simoes et al.
INFECTIOUS DISEASES AND THERAPY (2018)
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants
Qing Zhu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach
Wirichada Pan-Ngum et al.
VACCINE (2017)
Potential impact of a maternal vaccine for RSV: A mathematical modelling study
Alexandra B. Hogan et al.
VACCINE (2017)
Data and product needs for influenza immunization programs in low and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines
Kathleen M. Neuzil et al.
VACCINE (2017)
Projecting social contact matrices in 152 countries using contact surveys and demographic data
Kiesha Prem et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI)
Zbynek Stranak et al.
PLOS ONE (2016)
Vaccination strategies against respiratory syncytial virus
Dan Yamin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Reduced-Dose Schedule of Prophylaxis Based on Local Data Provides Near-Optimal Protection Against Respiratory Syncytial Virus
Daniel M. Weinberger et al.
CLINICAL INFECTIOUS DISEASES (2015)
Frequent Asymptomatic Respiratory Syncytial Virus Infections During an Epidemic in a Rural Kenyan Household Cohort
Patrick K. Munywoki et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children
Ruth A. Karron et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Environmental Drivers of the Spatiotemporal Dynamics of Respiratory Syncytial Virus in the United States
Virginia E. Pitzer et al.
PLOS PATHOGENS (2015)
Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding
P. K. Munywoki et al.
EPIDEMIOLOGY AND INFECTION (2015)
Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh
Helen Y. Chu et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
The Natural History of Respiratory Syncytial Virus in a Birth Cohort: The Influence of Age and Previous Infection on Reinfection and Disease
E. O. Ohuma et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
The behaviour of random forest permutation-based variable importance measures under predictor correlation
Kristin K. Nicodemus et al.
BMC BIOINFORMATICS (2010)
The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya
Rachel Ochola et al.
PLOS ONE (2009)
Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi district, Kenya
D. James Nokes et al.
CLINICAL INFECTIOUS DISEASES (2008)
Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents
Jacco Wallinga et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women
FM Munoz et al.
VACCINE (2003)
Share Paper
